Authors: Mitchell, DY Barr, WH Eusebio, RA Stevens, KAP Duke, FP Russell, DA Nesbitt, JD Powell, JH Thompson, GA

Citation: Dy. Mitchell et al., Risedronate pharmacokinetics and intra- and inter-subject variability uponsingle-dose intravenous and oral administration, PHARM RES, 18(2), 2001, pp. 166-170

Authors: Mitchell, DY St Peter, JV Eusebio, RA Pallone, KA Kelly, SC Russell, DA Nesbitt, JD Thompson, GA Powell, JH

Citation: Dy. Mitchell et al., Effect of renal function on risedronate pharmacokinetics after a single oral dose, BR J CL PH, 49(3), 2000, pp. 215-222

Authors: Corey, AE Agnew, JR Valentine, SN Nesbitt, JD Wagner, DL Powell, JH Thompson, GA

Citation: Ae. Corey et al., Comparative oral bioavailability of azimilide dihydrochloride in the fed and fasted states, BR J CL PH, 49(3), 2000, pp. 279-282

Authors: Mitchell, DY Eusebio, RA Sacco-Gibson, NA Pallone, KA Kelly, SC Nesbitt, JD Brezovic, CP Thompson, GA Powell, JH

Citation: Dy. Mitchell et al., Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers, J CLIN PHAR, 40(3), 2000, pp. 258-265

Authors: Mitchell, DY Heise, MA Pallone, KA Clay, ME Nesbitt, JD Russell, DA Melson, CW

Citation: Dy. Mitchell et al., The effect of dosing regimen on the pharmacokinetics of risedronate, BR J CL PH, 48(4), 1999, pp. 536-542

Authors: Corey, AE Agnew, JR Valentine, SN Nesbitt, JD Wagner, DL Powell, JH Thompson, GA

Citation: Ae. Corey et al., Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation, J CLIN PHAR, 39(12), 1999, pp. 1272-1276